Chill out: cooling therapy may ease chemo nerve pain in breast cancer
NCT ID NCT07345221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a cooling device called hilotherapy can reduce nerve damage symptoms (like numbness, tingling, or pain) caused by taxane chemotherapy in breast cancer patients. About 60 participants will either receive the cooling treatment during each chemo session or standard care. Researchers will track symptoms and quality of life over several months to see if cooling helps.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Acibadem Altunizade Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
-
Acibadem Maslak Hospital
RECRUITINGIstanbul, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?